In recent years, it has become accepted that immune cells play an active role in atherogenesis. Through various mouse studies, different subsets of lymphocytes have been shown to contribute to the atherosclerotic burden. However, mechanisms for how these cells contribute to atherogenesis or atheroprotection are not clearly understood. Moreover, an emerging concept is that lymphocytes and macrophages must communicate in the artery wall, but how this crosstalk influences atherogenesis is not clearly defined. In this PPG, we will study the immunobiology of atherosclerosis, with the goal of understanding how macrophages and lymphocytes communicate in the aortic wall to odulate atherogenesis. The PPG is comprised of three Projects and two Cores. In Project 1, Dr Hedrick will investigate how T regulatory lymphocyte function is changed during atherogenesis and subjects with Type 2 diabetes. In Project 2, Drs. Miller and Witztum will investigate how oxidized cholesteryl esters modulate TLR signaling in macrophages to influence metabolic endotoxemia and atherogenesis. Project 3 (McNamara) will study how B cells confer atheroprotection, and how the ranscriptional repressor Id3 influences B cell function in the aortic wall. The development of these projects involves extensive collaborations among all investigators. The Projects will be supported by two Cores, an Administrative Core and a Human Phenotyping and Immune Cell Core. This Human Core provides a translational aspect to our Program, providing blood samples, extensive subject phenotyping, and atherosclerosis assessment for subjects with and without Type 2 diabetes. As cardiovascular disease is a major risk factor for subjects with Type 2 diabetes, having access to such samples is a unique translational opportunity for our Program. Each project will utilize the Human Core to study immune cells from human subjects to establish functional links between candidate genes of interest and immune cell function in atherogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL055798-18
Application #
8707522
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Liu, Lijuan
Project Start
1997-09-08
Project End
2017-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
18
Fiscal Year
2014
Total Cost
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Verbeek, Rutger; Boekholdt, S Matthijs; Stoekenbroek, Robert M et al. (2016) Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study. J Lipid Res 57:697-705
Yang, Xiaohong; Lee, Sang-Rok; Choi, Yun-Seok et al. (2016) Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results. J Lipid Res 57:706-13
Harmon, Daniel B; Srikakulapu, Prasad; Kaplan, Jennifer L et al. (2016) Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance. Arterioscler Thromb Vasc Biol 36:682-91
Choi, Soo-Ho; Kim, Jungsu; Gonen, Ayelet et al. (2016) MD-2 binds cholesterol. Biochem Biophys Res Commun 470:877-80
Park, Kiwon; Mikulski, Zbigniew; Seo, Goo-Young et al. (2016) The transcription factor NR4A3 controls CD103+ dendritic cell migration. J Clin Invest 126:4603-4615
Choi, Soo-Ho; Sviridov, Dmitri; Miller, Yury I (2016) Oxidized cholesteryl esters and inflammation. Biochim Biophys Acta :
Yeang, Calvin; Cotter, Bruno; Tsimikas, Sotirios (2016) Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis. Cardiovasc Drugs Ther 30:75-85
Tsimikas, Sotirios (2016) Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease risk. Curr Opin Endocrinol Diabetes Obes 23:157-64
Leibundgut, Gregor; Lee, Jun-Hee; Strauss, Bradley H et al. (2016) Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina. J Thromb Thrombolysis 41:569-80
Cheng, Hsin-Yuan; Gaddis, Dalia E; Wu, Runpei et al. (2016) Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest 126:3236-46

Showing the most recent 10 out of 188 publications